- Home
- DBCA vs MLAB Comparison
DBCA vs MLAB Comparison
Compare DBCA & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DBCA | MLAB |
|---|---|---|
| Founded | 2025 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Industrial Machinery/Components |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 427.3M | 461.9M |
| IPO Year | 2026 | 1995 |
Fundamental Metrics
Financial Performance| Metric | DBCA | MLAB |
|---|---|---|
| Price | $9.88 | $102.90 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $94.00 |
| AVG Volume (30 Days) | 60.2K | ★ 85.1K |
| Earning Date | N/A | 05-27-2026 |
| Dividend Yield | N/A | ★ 0.67% |
| EPS Growth | N/A | ★ 99.24 |
| EPS | N/A | ★ 1.95 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.07 |
| Revenue Next Year | N/A | $5.41 |
| P/E Ratio | ★ N/A | $52.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.83 | $59.63 |
| 52 Week High | $9.90 | $128.55 |
Technical Indicators
Market Signals| Indicator | DBCA | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 59.19 | 61.58 |
| Support Level | $9.86 | $69.73 |
| Resistance Level | $9.90 | $105.01 |
| Average True Range (ATR) | 0.01 | 4.37 |
| MACD | 0.00 | -0.11 |
| Stochastic Oscillator | 66.67 | 73.75 |
Price Performance
Historical ComparisonAbout DBCA D. Boral Acquisition I Corp. Class A Ordinary Shares
D Boral Acquisition I Corp is a blank check company. It is formed as a BVI business company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.